You've seen the ads or heard the term in a genetics appointment: polygenic risk scores for autism. The promise sounds appealing: a test that calculates your child's genetic risk based on hundreds of DNA variants linked to autism spectrum disorder. But what these scores tell you is narrower and less actionable than the marketing suggests.

Polygenic risk scores provide probability estimates, not diagnoses. They can't confirm whether your child has autism, explain why they do, or guide treatment decisions. For most families, they offer research insights rather than clinical answers. Here's what you need to know.

What Polygenic Risk Scores Measure

A polygenic risk score aggregates information from hundreds or thousands of genetic variants across the genome. Each variant contributes a small amount to autism likelihood. The score adds these contributions to estimate where someone falls on a risk spectrum compared to the general population.

The test looks at common genetic variants, each of which individually has minimal impact. Someone with a higher polygenic score carries more of these risk-associated variants than someone with a lower score. But the score is a population-level statistic, not an individual prediction.

Researchers use polygenic risk scores to study how genetic factors combine to influence autism traits across large groups. They're valuable for understanding genetic architecture: which combinations of variants tend to appear together in people with autism. The research advances understanding of autism's genetic complexity, but it doesn't yet translate into actionable guidance for your child.

What the Numbers Mean

A polygenic risk score might report that your child has a 15% elevated genetic risk for autism compared to the average. That doesn't mean your child has a 15% chance of having autism. It means that among people with similar genetic profiles, autism occurs somewhat more frequently than in the general population.

The baseline autism prevalence is roughly 1 in 36 children. A 15% elevated genetic risk might shift that to approximately 1 in 31. The difference exists, but it's modest. More importantly, the score doesn't account for environmental factors, prenatal exposures, or the hundreds of rare genetic variants that clinical tests like chromosomal microarray or whole genome sequencing can detect.

Think of it like a weather forecast for next year. The score can tell you that rain is statistically more likely in March than in July, but it can't tell you whether it'll rain on any specific day. Autism diagnosis depends on developmental observation and clinical assessment, not a probability estimate derived from DNA alone.

Why These Scores Lack Clinical Utility

Clinical utility means a test result changes medical management: it leads to a different treatment, earlier intervention, or altered care plan. Polygenic risk scores for autism don't meet that threshold yet.

If your child already has an autism diagnosis, the score doesn't explain which interventions will work best. It doesn't identify treatable medical conditions like metabolic disorders or chromosomal abnormalities that clinical genetic tests can find. If your child doesn't have an autism diagnosis, the score doesn't confirm or rule out autism. Diagnosis still requires developmental evaluation by a clinician.

The American College of Medical Genetics and Genomics has stated that polygenic risk scores are not ready for routine clinical use. They're research tools. Some companies offer them commercially, but ordering one won't change your pediatrician's recommendations or your child's eligibility for services.

How Polygenic Scores Differ from Clinical Genetic Testing

Genetic testing for developmental disabilities includes tests like chromosomal microarray (CMA) and whole genome sequencing (WGS). These tests look for rare, high-impact genetic changes (deletions, duplications, or mutations) that can directly cause autism or co-occurring conditions.

CMA identifies chromosomal abnormalities in roughly 10% of children with autism. WGS finds clinically relevant variants in about 34%. When one of these tests identifies a genetic cause, it can guide medical surveillance, connect families to condition-specific resources, or inform family planning decisions.

Polygenic risk scores don't do that. They summarize hundreds of common variants, each with tiny individual effects. A high polygenic score doesn't point to a specific genetic syndrome or treatable condition. A low score doesn't rule out a rare genetic cause that CMA or WGS might detect.

If you're considering genetic testing for your child, start with the tests that have established clinical utility. Genetic counseling can help you understand which tests are appropriate for your child's situation and what the results might reveal.

When Polygenic Scores Might Be Offered

You're most likely to encounter polygenic risk scores in research studies. Universities and research hospitals sometimes offer them as part of autism genetics research projects. Participation is voluntary, and the results typically come with genetic counseling to explain what they do and don't mean.

Some direct-to-consumer genetic testing companies include polygenic risk scores in their reports. These companies market the scores as part of broader health risk panels. The autism risk score sits alongside estimates for conditions like diabetes or heart disease, all calculated from the same DNA sample.

If you're offered a polygenic risk score, ask three questions before agreeing:

• Will this result change my child's diagnosis, treatment, or care plan?
• What will I learn that clinical genetic testing wouldn't tell me?
• Is genetic counseling included to interpret the result?

If the answers are "no," "nothing specific," and "no," you're paying for information that won't help you make decisions.

What Families Should Prioritize Instead

If you're trying to understand your child's autism from a genetic perspective, clinical genetic testing offers more value. Chromosomal microarray is recommended as a first-tier test for children with autism or developmental delay. Whole exome or whole genome sequencing may be appropriate if CMA doesn't find a cause and your child has additional medical concerns.

These tests identify rare genetic variants that can explain autism, reveal co-occurring medical conditions that need monitoring, or connect you to families with the same genetic diagnosis. They're covered by many insurance plans when autism or developmental delay is documented. Polygenic risk scores generally aren't covered because they lack clinical utility.

Genetic counseling is valuable whether or not you pursue testing. A genetic counselor can review your child's history, explain which tests might be informative, and help you weigh the potential benefits against cost and complexity. Many families don't realize genetic counseling is available after a diagnosis, not just for family planning decisions before pregnancy.

What This Means for Research

Polygenic risk scores are advancing autism research. They help scientists identify biological pathways that common genetic variants influence. They reveal how genetic background interacts with rare mutations to shape autism traits. Over time, this research may lead to better understanding of autism subtypes or targeted interventions.

But research progress and clinical readiness are different timelines. The tools that researchers use to study populations aren't always the tools that help individual families make care decisions. Polygenic risk scores are in the first category. Clinical genetic tests are in the second.

If you're passionate about contributing to research, participating in studies that include polygenic scoring can be meaningful. The data you provide helps scientists refine these tools. Just recognize that the score you receive is a contribution to future knowledge, not guidance for today's decisions.

Questions to Ask if You're Offered a Polygenic Risk Score

Will this score affect my child's eligibility for early intervention or school services?

No. Autism services are based on developmental needs and clinical diagnosis, not genetic risk estimates.

Can a high polygenic risk score diagnose autism?

No. Diagnosis requires clinical evaluation. A high score indicates genetic similarity to people with autism, but it doesn't confirm the condition.

If my child has autism, will the score explain why or suggest specific therapies?

No. The score reflects population-level risk from common variants. It doesn't identify a single cause or guide treatment selection.

Does a low polygenic risk score mean my child won't develop autism?

No. Many children with autism have average or low polygenic scores. Rare genetic variants, environmental factors, and prenatal exposures aren't captured in these scores.

Should I get a polygenic risk score before pursuing clinical genetic testing?

No. Start with tests that have established clinical utility: chromosomal microarray or whole genome sequencing if recommended by your child's provider or genetic counselor.

If I participate in research that generates a polygenic risk score, do I have to receive the result?

No. Most studies offer the option to decline results. Discuss this with the research team before enrolling.